Skip to main content

p38 protein, the saviour of breast cancer cells 'in extremis'

Images

Participants

Contact

Image
Section Head of Communication & Outreach
Tel.+34 93 40 37255

El País, Ara, La Razón, El Economista, Medical Xpress, News-Medical, among other national and international media, have published an article about recent research led by IRB Barcelona, which reveals a new protective mechanism for tumour cells in breast cancer and identifies novel therapeutic targets to treat this disease.

Link to El País

Link to El Economista

Link to Medical Xpress

Link to News-Medical

Attachment:
Ara (català) (167.56 KB)

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).